aristolochic acid i has been researched along with losartan potassium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, W; Zhang, J | 1 |
Aoki, T; Hamano, Y; Hatano, M; Kimura, R; Ogawa, M; Shirai, R; Ueda, S; Yokosuka, O | 1 |
Angeletti, A; Cantarelli, C; Cravedi, P; D'Agati, VD; Donadei, C; Fiaccadori, E; Guglielmo, C; Hartzell, S; Heeger, PS; Horwitz, JK; La Manna, G; Madsen, JC; Maggiore, U; Xiong, H | 1 |
3 other study(ies) available for aristolochic acid i and losartan potassium
Article | Year |
---|---|
Protective effect of erythropoietin against aristolochic acid-induced apoptosis in renal tubular epithelial cells.
Topics: Animals; Apoptosis; Aristolochic Acids; bcl-X Protein; Caspase 3; Cells, Cultured; Cytoprotection; DNA Fragmentation; Epithelial Cells; Erythropoietin; In Situ Nick-End Labeling; Kidney Tubules; LLC-PK1 Cells; Proliferating Cell Nuclear Antigen; Recombinant Proteins; Swine | 2008 |
Low-dose darbepoetin alpha attenuates progression of a mouse model of aristolochic acid nephropathy through early tubular protection.
Topics: Animals; Apoptosis; Aristolochic Acids; Cell Proliferation; Darbepoetin alfa; Disease Models, Animal; Erythropoietin; Fibrosis; Kidney Tubular Necrosis, Acute; Kidney Tubules; Male; Mice; Mice, Inbred C3H | 2010 |
Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease.
Topics: Animals; Aristolochic Acids; Cells, Cultured; Disease Models, Animal; Epoetin Alfa; Erythropoietin; Female; Humans; Immediate-Early Proteins; Interleukin-17; Lupus Nephritis; Male; Mice; Mice, Inbred MRL lpr; Mice, Transgenic; Nephritis, Interstitial; Phosphorylation; Primary Cell Culture; Protein Serine-Threonine Kinases; Receptors, Erythropoietin; Receptors, Interleukin; Severity of Illness Index; T-Lymphocytes, Regulatory; Th17 Cells | 2019 |